Download 1% Allele frequency of variant +++ + ++ Clinical impact

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Personalized
Health Symposium
22 Sept 2016
Human Genomics of
Infection and Immunity
Jacques Fellay
EPFL School of Life Sciences
Swiss Institute of Bioinformatics
Service of Infectious Diseases, CHUV
@jacques.fellay
© ALAIN HERZOG
 Exploiting human genetic variation
to improve human health
Identification of relevant
genetic variant
Prediction
models
Understanding of
underlying biology
Individualized
healthcare
New drug or
vaccine targets
Allele frequency of variant
<<1%
>1-3%
Sequencing
+++
Hunting for
host genetic
variants
++
Clinical impact
Genotyping
+
Allele frequency of variant
<<1% viral
Fulminant
hepatitis
Opportunistic
infections & cancers
Severe viral
respiratory infections
Pediatric
sepsis
Generation of broadly
neutralizing antibodies
Ectyma
gangrenosum
+++
>1-3%
Spontaneous
control of HIV
Decay of the
++
HIV reservoir
Clinical impact
IgG responses to
common infections
Chronic viral
hepatitis
+
Severe viral respiratory infections
• 1-2% hospitalization
• 10% PICU admission
• 50% no known risk factors
<1 in 1000 live
birth
Healthy children who develop unusually severe
symptoms upon infection with common respiratory
viruses carry rare causal genetic defects
Study participants
Inclusion criteria
 Consent of legal guardian
 Age 0-3 years
 Ventilation support needed
Exclusion criteria
!
!
!
!
!
Prematurity
Immunosuppression
Chronic disease
Sickle cell anemia
Comorbidity
120 samples (blood for DNA & RNA + NPA)
Exome sequencing, RNA sequencing, viral PCR
Patient recruitment
Target enrichment
Variant calling
CAA GTA AAC ATA GGA CTT CTT
CAA GTA AAC ATA GGA CAT CTT
DNA extraction and
normalization
Exome sequencing
Pathogen sequencing
Variant annotation &
frequency estimation
G>A
ExAC
Stop-gain
DNA pooling and
bar-coding
Short read
alignment
Functional characterization
& experimental confirmation
Putative loss-of-function variants
in the IFIH1 gene
Splice-site
1 hom, 3 het
Stop-gained
1 het
Splice-site
3 het
IFIH1 (MDA5)
is a pattern
recognition
receptor for
long dsRNA
Reikine S. et al. Front Immunol, 2014
IFIH1-Δ8: 39 aa missing
IFIH1-Δ14: 153 aa missing
IFIH1-ΔCTD: 399 aa missing
Protein expression in vivo
Both IFIH1-wt and IFIH1-Δ14 are expressed in BPMCs upon RSV infection
Protein stability
IFIH1-LoFs are less stable & they reduce wt stability
Interferon β induction
IFIH1-LoFs cannot induce IFNβ and interfere with wt function
LoF variants in IFIH1 cause a pathogenspecific primary immunodeficiency
• Scientific relevance: human genetics informs on
immunological principles, which can help identify
therapeutic or vaccine targets
• Clinical relevance: immediate impact for patients
and families, potential inclusion in screening
programs
Clinical
impact
Clinical
observation
Functional
follow-up
Recruitment,
sample collection
Genomics,
transcriptomics
Samira Asgari
Istvan Bartha
Chris Hammer
Christian Thorball
Petar Scepanovic
Nimisha Chaturvedi
Olivier Naret
Thomas Junier
Alessandro Borghesi
Flavia Hodel
Study participants & families, Pediatric ICUs
Dominique Garcin and Caroline Tapparel, University of Geneva
Keith Harshman & team, Lausanne Genomic Technologies Facility
Ioannis Xenarios & team, Vital-IT Computing Center
Related documents